title: Reply to a. Molfino et Al.
authors.affiliation: Telemark Hospital Trust, Skien; Norwegian University of Science and Technology, Trondheim, Norway paor@sthf.no.
authors.forename: Ørnulf
authors.initials: Ø
authors.lastname: Paulsen
authors.affiliation: Oslo University Hospital; University of Oslo, Oslo, Norway.
authors.forename: Nina
authors.initials: N
authors.lastname: Aass
authors.affiliation: St Olavs Hospital, Trondheim University Hospital; Norwegian University of Science and Technology, Trondheim, Norway.
authors.forename: Pål
authors.initials: P
authors.lastname: Klepstad
authors.affiliation: Norwegian University of Science and Technology; St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
authors.forename: Stein
authors.initials: S
authors.lastname: Kaasa
mesh_terms: D000855:Anorexia / Q000188:drug therapy*; D005221:Fatigue / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D009369:Neoplasms / Q000150:complications*; D010146:Pain / Q000188:drug therapy*
chemical_list: D005938:Glucocorticoids; D008775:Methylprednisolone